Source: The Guardian · Nov 11, 2026

Photograph: Kellie French/The Guardian

Quick answer

Sali Hughes's Guardian beauty column reviews Bioderma Atoderm AD Intensive Baume, describing a thick but readily absorbed lotion. Hughes reports finding it comforting on her own dry skin, while distinguishing that personal experience from treatment of eczema. The Guardian

Key facts

  • The column describes Bioderma's view that eczema-affected skin lacks a particular combination of 15 lipids and explains that the new product was designed around replacing them. The Guardian

  • Hughes cites a study involving 500 people and reports claims of rapid itch relief and an 88% reduction in the urge to scratch. The Guardian

  • The NHS describes atopic eczema as a condition that can be managed with treatments including emollients and, when required, topical steroids and other prescribed options. The Guardian

A beauty review is not the same as an eczema cure

Sali Hughes's Guardian column recommends Bioderma's Atoderm AD Intensive Baume for dry skin and discusses the brand's research into eczema. Her own reported experience concerns dryness: she says she does not currently have eczema and has used the lotion since late August. That distinction is central to reading the recommendation. A favourable account of texture and moisturising comfort does not establish that a product cures an inflammatory skin condition or replaces prescribed treatment.

The product focuses on the skin barrier

The column describes Bioderma's view that eczema-affected skin lacks a particular combination of 15 lipids and explains that the new product was designed around replacing them. The brand presented research at the European Academy of Dermatology and Venereology conference in Vienna. Those are the manufacturer's explanation and presentation of its work, as reported in the column. They provide context for the formula without turning a conference announcement into independent verification of every marketing claim. Reporting context: The Guardian

Trial figures need their original context

Hughes cites a study involving 500 people and reports claims of rapid itch relief and an 88% reduction in the urge to scratch. The column does not supply enough methodological detail to assess those figures as a complete clinical paper. Readers should therefore understand them as reported product-study results rather than a guaranteed personal outcome. A strong percentage also leaves unanswered questions about the comparison group, measurement period and which participants experienced the improvement. Reporting context: The Guardian

Texture can determine whether a moisturiser gets used

Hughes describes the product as closer to a thick lotion than the word balm might suggest. In her experience it absorbs comfortably and leaves skin supple rather than heavily greasy. She also notes the absence of fragrance and says it suits her autumn dryness, while expecting she may need something richer in colder weather. These observations are useful as one reviewer's account of everyday use. They are separate from the more consequential question of treating active eczema.

Reporting context: The Guardian

NHS guidance places moisturisers within a wider plan

The NHS describes atopic eczema as a condition that can be managed with treatments including emollients and, when required, topical steroids and other prescribed options. Avoiding individual triggers and using suitable skin-care routines can also matter. That context explains why barrier-supporting moisturisers have a role without implying that a new cosmetic texture settles the whole condition. Worsening inflammation, signs of infection or treatment that is not working require an assessment suited to the individual's symptoms.

Reporting context: The Guardian

Another recommendation concerns very dry skin

The column also welcomes the return of The Body Shop's Olive Body Butter within its relaunched range. Hughes describes it as useful for substantial dryness, drawing on her own experience rather than a comparative trial. It is a separate product with a separate formula; the two should not be treated as equivalent because both are rich body moisturisers. The reported starting prices, £26 for the Bioderma product and from £7 across the Body Butter range, also need checking against the actual size and current retailer listing. Reporting context: The Guardian

Choose according to the problem being addressed

Someone comparing body lotions may reasonably care about fragrance, richness, absorption and price. Someone managing eczema also needs to consider the treatment plan and how their own skin responds. The review supplies observations about the first set of questions, while the NHS provides the broader medical framework. Keeping those sources in their appropriate roles makes the recommendation more useful: it can help narrow a product choice without promising a universal result from one person's experience.

Reporting context: The Guardian

Reporting and further reading

www.nhs.uk: Atopic eczema

Sources and editorial notes

This article compiles the linked reporting. Allegations, projections and research findings retain their original qualifications; this page does not represent independent field reporting or expert medical review.

November 17, 2026: Replaced repeated summary and FAQ templates, added source attribution and image description, and clarified the distinction between source publication and site edits. This editorial update is not an independent fact-check certification.

Report an error or read the update policy

F
Compiled by

Folio News Desk

Editorial compilation from the linked reports, with AI-assisted organisation. Read our sourcing policy and corrections process.